The Discounted Cash Flow (DCF) valuation of Sino Biopharmaceutical Ltd (1177.HK) is 5.43 HKD. With the latest stock price at 5.91 HKD, the upside of Sino Biopharmaceutical Ltd based on DCF is -8.1%.
Based on the latest price of 5.91 HKD and our DCF valuation, Sino Biopharmaceutical Ltd (1177.HK) is a sell. selling 1177.HK stocks now will result in a potential gain of 8.1%.
| Range | Selected | |
| WACC / Discount Rate | 6.4% - 8.9% | 7.6% |
| Long-term Growth Rate | 2.0% - 4.0% | 3.0% |
| Fair Price | 3.85 - 10.01 | 5.43 |
| Upside | -34.9% - 69.5% | -8.1% |